CN105875913A - 一种红景天茶及其制备方法 - Google Patents
一种红景天茶及其制备方法 Download PDFInfo
- Publication number
- CN105875913A CN105875913A CN201410816991.0A CN201410816991A CN105875913A CN 105875913 A CN105875913 A CN 105875913A CN 201410816991 A CN201410816991 A CN 201410816991A CN 105875913 A CN105875913 A CN 105875913A
- Authority
- CN
- China
- Prior art keywords
- radix
- tea
- dried
- rhodiola rosea
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 244000269722 Thea sinensis Species 0.000 title abstract description 25
- 244000042430 Rhodiola rosea Species 0.000 title abstract 7
- 235000003713 Rhodiola rosea Nutrition 0.000 title abstract 7
- 239000011449 brick Substances 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000009636 Huang Qi Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 5
- 238000010025 steaming Methods 0.000 claims description 5
- 241000276425 Xiphophorus maculatus Species 0.000 claims description 4
- 229910003460 diamond Inorganic materials 0.000 claims description 4
- 239000010432 diamond Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 241001165494 Rhodiola Species 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 2
- 241001122767 Theaceae Species 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 26
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 239000000047 product Substances 0.000 abstract description 8
- 240000005979 Hordeum vulgare Species 0.000 abstract description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract description 7
- 235000008434 ginseng Nutrition 0.000 abstract description 6
- 150000002632 lipids Chemical group 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 244000124209 Crocus sativus Species 0.000 abstract 3
- 235000015655 Crocus sativus Nutrition 0.000 abstract 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 2
- 240000004371 Panax ginseng Species 0.000 abstract 2
- 235000002789 Panax ginseng Nutrition 0.000 abstract 2
- 244000185386 Thladiantha grosvenorii Species 0.000 abstract 2
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229940010454 licorice Drugs 0.000 abstract 2
- 230000035622 drinking Effects 0.000 abstract 1
- 230000001815 facial effect Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 30
- 235000013616 tea Nutrition 0.000 description 19
- 230000001737 promoting effect Effects 0.000 description 12
- 230000033228 biological regulation Effects 0.000 description 11
- 230000036541 health Effects 0.000 description 11
- 206010016256 fatigue Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 239000003814 drug Substances 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 229920000945 Amylopectin Polymers 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000019225 fermented tea Nutrition 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- IPMYMEWFZKHGAX-UHFFFAOYSA-N Isotheaflavin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C(C1=C2)=CC(O)=C(O)C1=C(O)C(=O)C=C2C1C(O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- UXRMWRBWCAGDQB-UHFFFAOYSA-N Theaflavin Natural products C1=CC(C2C(CC3=C(O)C=C(O)C=C3O2)O)=C(O)C(=O)C2=C1C(C1OC3=CC(O)=CC(O)=C3CC1O)=CC(O)=C2O UXRMWRBWCAGDQB-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000002156 adsorbate Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000003555 analeptic effect Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 231100000284 endotoxic Toxicity 0.000 description 1
- 230000002346 endotoxic effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- IPMYMEWFZKHGAX-ZKSIBHASSA-N theaflavin Chemical compound C1=C2C([C@H]3OC4=CC(O)=CC(O)=C4C[C@H]3O)=CC(O)=C(O)C2=C(O)C(=O)C=C1[C@@H]1[C@H](O)CC2=C(O)C=C(O)C=C2O1 IPMYMEWFZKHGAX-ZKSIBHASSA-N 0.000 description 1
- 229940026509 theaflavin Drugs 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种红景天茶及其制备方法,属人用保健食品,特别是以红景天、藏红花、青稞为主要原料而制成的保健饮品,以及它的制备方法。制备其活性成分原料包括红景天、藏红花、青稞、高原刺五加、手掌参、罗汉果、人参果、黄芪、甘草、砖茶。制备方法包括:1)将红景天、高原刺五加、罗汉果、黄芪、甘草煎煮提取,浸膏干燥,粉碎备用;2)将青稞蒸煮,干燥,炒制粉碎成细粉备用;3)将藏红花、手掌参、人参果、砖茶粉碎备用;4)将上述备用物混匀,制粒,压成圆形或菱形片状,干燥即得。(也可加纯净水制成饮料,灭菌,装罐或装瓶即可)。其优点是制备活性成分的原料配伍合理科学,营养成份丰富,含有多种人体必需的有益物质,是一种具有抗疲劳、补气活血、调节血脂功能的保健饮品,特别适合于精神不振、容易疲倦、血脂高、面容憔悴的人群饮用。
Description
技术领域:
一种红景天茶及其制备方法,属天然保健食品,特别是以植物为原料的保健食品,以及它的制备方法。
背景技术:
随着人们生活节奏的加快,物质生活水平不断提高,工作压力很大,容易疲劳倦怠,血脂过高,气血不足,存在亚健康问题,要解决这个问题,需要抗疲劳、补气活血、调节血脂的保健饮品。目前市场上治疗的药物很多,但是具有调节血脂、抗疲劳和补气活血功能的保健茶却不多。
发明内容:
本发明要解决的问题就是针对以上不足而提供一种具有抗疲劳、补气活血、调节血脂功能的保健茶产品,以及它的制备方法。其技术方案如下:
制备其活性成分的原料是下列重量份的原料:
红景天15-25、藏红花1-3、青稞15-35、高原刺五加15-25、手掌参5-10、罗汉果10-15、人参果10-15、黄芪10-15、甘草15-25、砖茶15-30。
其制备方法包括以下步骤:
1)将红景天15-25、高原刺五加15-25、罗汉果10-15、黄芪10-15、甘草15-25。加水煎煮提取三次,合并滤液,浓缩成浸膏,干燥粉碎成细粉备用;
2)将青稞蒸煮,干燥,炒制粉碎成细粉备用;
3)将藏红花、手掌参、人参果、砖茶粉碎备用;
4)A,将上述备用物混匀,制粒,压成圆形或菱形片状,干燥即得。
B,将上述备用物混匀,加入纯净水,搅拌均匀,煮沸,冷却,过滤,装罐或瓶即可。
用于本发明的原料具有的特性和功能是:
红景天:甘、苦、平。归肺、心经。益气活血、通脉平喘。用于气虚血瘀、胸闷心痛、中风偏瘫、倦怠气喘。现代研究具有抗疲劳、耐缺氧、增强耐力的作用。能迅速提高血红蛋白与氧的结合能力,提高血氧饱和度,降低机体的耗氧量,增加运动耐力,恢复运动后疲劳。
1.现代医学研究证明,红景天中含有35种微量元素,18种氨基酸,维生素A、D、E和抗衰老活性超氧化物,其营养成分齐全且配伍合理,在目前所发现的植物中是罕见的。在药理学方面,现已证明红景天有中枢兴奋作用及“适应原样”效应,能消除人“累”,加强记忆力和注意力,使加快收缩频率的心脏恢复正常。
2.近年来国内外的药学工作者对红景天进行了深入的研究,提出了红景天具有类似人参“扶正固本”的“适应原样”的作用,而且在某些方面还优于人参,没有人参兴奋作用过强的不足。红景天所含有效成分具有强心镇静、调节新陈代谢、调节神经系统和内分泌系统双向调节血糖、血压的作用,用于治疗脑血管疾病,老年性心肌能衰竭、糖尿病、低血压等症,也用于病后体虚、年老体弱、神经乏力等。据研究,红景天系″全能性″新型药物,具有养肺、清热、滋补元气、退烧、利肺之功效,主治性机能衰退、糖尿病、低血压肺炎、神经麻痹症、气管炎等症。国外把高山红景天作为″适应原″样药,广泛应用于抗疲劳,抗衰老和提高脑力和体力机能等方面。可作为飞行员、宇航员、潜水员、高山工作者以及一切处在不正常环境中的工作人员增强抵抗力的良药。它对提高体力和脑力劳动效率均有明显的双向调节作用,是理想的强壮剂。
藏红花:味甘性平,能活血化瘀,散郁开结,止痛。用于治疗忧思郁结,胸膈痞闷,吐血,伤寒发狂,惊怖恍惚,妇女经闭,血滞月经不调,产后恶露不尽,瘀血作痛,麻疹,跌打损伤等。国外用作镇静、驱风剂。活血化瘀,凉血解毒,解郁安神。具有活血化瘀、凉血解毒、解郁安神、美容养颜等功效,对预防心脑血管疾病、调节肝肾功能等效果显著。
青稞:青稞,味咸,性平凉。补中益气。主脾胃气虚;四肢无力;大便稀溏。青稞具有丰富的营养价值和突出的医药保健作用。在高寒缺氧的青藏高原,为何不乏百岁老人,这与常食青稞,与青稞突出的医疗保健功能作用是分不开的。据《本草拾遗》记载:青稞,下气宽中、壮精益力、除湿发汗、止泻。藏医典籍《晶珠本草》更把青稞作为一种重要药物,用于治疗多种疾病。
1.富含β一葡聚糖:青稞是世界上麦类作物中β一葡聚糖最高的作物,据检测青稞β-葡聚糖平均含量为6.57%,优良品种青稞25可8.6%,是小麦平均含量的50倍。β-葡聚糖通过减少肠道粘膜与致癌物质的接触和间接抑制致癌维生物作用来预防结肠癌;通过降血脂和降胆固醇的合成预防心血管疾病:通过控制血糖防治糖尿病。具有提高机体防御能力、调节生理节律的作用。另根据美国科学研究表明,青稞除β-葡聚糖外,青稞还含有一种专门的胆固醇抑制因子,其含量约每公斤100-150毫克。
2.富含膳食纤维:青稞的总疗效纤维含量16%,其中不可溶性疗效纤维9.68%,可溶性疗效纤维6.37%,前者是小麦的8倍,后者是小麦的15倍。膳食纤维具有清肠通便,清除体内毒素的良好功效,是人体消化系统的清道夫。
3.富含支链淀粉:青稞淀粉成分独特,普遍含有74-78%的支链淀粉,近年西藏自治区农牧科学院培育的新品种青稞25支链淀粉达到或接近100%。支链淀粉含大量凝胶黏液,加热后呈弱碱性,对胃酸过多有抑制作用。对病灶可起到缓解和屏障保护作用。
4.稀有营养成分:100g青稞面粉中含硫胺素(维生素B1)0.32mg,核黄素(维生素B2)0.21mg,尼克酸3.6mg;维生素E0.25mg。这些物质对促进人体健康发育均有积极的作用关系。
5.富含微量元素含有多种有益人体健康的无机元素钙、磷、铁、铜、锌和微量元素硒等矿物元素。硒是联合国卫生组织确定的人体必需的微量元素,而且是该组织目前唯一认定的防癌抗癌元素。
高原刺五加:益气健脾,补肾安神。用于脾肾阳虚,体虚乏力,食欲不振,腰膝酸痛,失眠多梦。现代研究具有抗疲劳的作用。
手掌参:佛手参含有人参皂苷、多种糖类、维生素及矿物质等成分。其性温润,味甘甜,有补肾益气、润肺利气、安神增智的功效。具有补肾益气、生津润肺、固本养生、强壮机体的功效,有不老草之称。
罗汉果:甘、凉,无毒;入肺、脾经;清肺润肠、清热通便。有清肺止咳、润肠通便之功效,对烟酒过度等引起的声音嘶哑、咽干口渴等尤为有效。可调降血糖值,改善糖尿病。有清肺止咳、润肠通便之功效,可保嗓子,还可治疗风热袭肺引起的声音嘶哑、咳嗽不爽、咽痛等症。清热润肺,滑肠通便。用于肺火燥咳,咽痛失音,肠燥便秘。
人参果:具有抗衰老、抗肿瘤、降低血糖、稳定血压、糖尿病;强心、益智、减肥、提高免疫功能及增白美容等功效。
黄芪:有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。
甘草:有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药的作用。
砖茶:①清脂肪,减肥胖:茶中的多酚类及其氧化产物能溶解脂肪,促进脂类物质排出;还可活化蛋白质激酶,加速脂肪分解,降低体内脂肪的含量。因此黑茶被韩国人称为“瘦身茶”;日本人称为“美容茶”;台湾人称为“消食茶”。
②清肠胃,助消化:黑茶富含膳食纤维,具有调理肠胃的功能,清肠胃;且有益生菌参与,能改善肠道微生物环境,助消化。我国民间有利用老黑茶治疗腹胀、痢疾、消化不良的传统。
③清血管,降三高,黑茶中富含茶黄素,能软化血管,有效清除血管壁内的粥样物质,被称为“心血管的清道夫”;茶氨酸有效抑制血压升高,类黄酮物质能使血管壁松弛,增加血管的有效直径,降低血压;茶多糖具有类似胰岛素的作用,降低血糖含量;多酚类及其氧化产物能溶解脂肪,促进血管内脂类物质排出,降低血液中胆固醇的含量。
④清毒素,护肝肾:黑茶中独特的益生菌的功能因子和多酚类氧化物、儿茶素等多种化合物成分,参与人体内新陈代谢,对人体内脏具有特殊的净化功能,吸附体内的有毒物质(酒精、重金属、体内垃圾)排出体外,能深层排毒;又对病菌有抑制作用,保护肝肾。
砖茶具有消食去腻、降脂减肥、降三高、解酒、暖胃、安神的功效,另外,还有补充膳食营养、抑制动脉硬化等的作用。
与现有技术相比本发明的优点是:以上各原料配伍,产生很好的协同作用,制成的产品具有抗疲劳、调节血脂、补气活血的保健功能。
为表明本发明产品对抗疲劳、调节血脂功能的效果,对100名年龄在35-70岁之间,无心血管、肝、肾等严重原发性疾病的受试人作了系统的观察,受试人群服用本发明产品前具疲劳倦怠、精神不振、血脂高等症状。
服用方法:每次服用一袋颗粒(8克),每天三次。观察期间,受试者需保持合理饮食结构及作息制度。(或每次一罐,每日三次)
服用时间:30天。
有效标准:
疲劳功能改善正常标准:食欲正常,精神舒畅,心情舒顺,面色红润、气色良好,生活有规律。
返馈结果:30天以后100名受试人中有99名食欲正常,精神舒畅,心情舒顺,面色红润、气色良好,生活有规律。抗疲劳功能有效率达到99%。
具体实施方式:
实施例一:
按下述重量份称取各原料:
红景天15份、藏红花3份、青稞35份、高原刺五加15份、手掌参5份、罗汉果10份、人参果10份、黄芪10份、甘草15份、砖茶30份。
其制备方法包括以下步骤:
1)将红景天15份、高原刺五加15份、罗汉果10份、黄芪10份、甘草15份。加6倍量水,煎煮提取三次,每次3小时,合并滤液,将滤液浓缩成相对密度1.20的浸膏,在温度为70℃~80℃,真空度为0.08~0.1Mpa的条件下将浸膏干燥,粉碎成150目细粉备用;
2)将青稞蒸煮,干燥,炒制粉碎成150目细粉备用;
3)将藏红花、手掌参、人参果、砖茶粉碎成150目细粉备用;
4)B,将上述备用物混匀,加入纯净水,搅拌均匀,煮沸,冷却,过滤,装罐或瓶即可。
实施例二:
按下述重量份称取各原料:
红景天20份、藏红花2份、青稞25份、高原刺五加20份、手掌参8份、罗汉果12份、人参果12份、黄芪12份、甘草25份、砖茶20份。
其制备方法包括以下步骤:
1)将红景天20份、高原刺五加20份、罗汉果12份、黄芪12份、甘草25份。加7倍量水,煎煮提取三次,每次3小时,合并滤液,将滤液浓缩成相对密度1.20的浸膏,在温度为70℃~80℃,真空度为0.08~0.1Mpa的条件下将浸膏干燥,粉碎成120目细粉备用;
2)将青稞蒸煮,干燥,炒制粉碎成120目细粉备用;
3)将藏红花、手掌参、人参果、砖茶粉碎成120目细粉备用;
4)A,将上述备用物混匀,制粒,压成圆形或菱形片状,干燥即得。
实施例三:
按下述重量份称取各原料:
红景天25份、藏红花1份、青稞15份、高原刺五加25份、手掌参10份、罗汉果15份、人参果15份、黄芪15份、甘草15份、砖茶15份。
其制备方法包括以下步骤:
1)将红景天25份、高原刺五加25份、罗汉果15份、黄芪15份、甘草15份。加8倍量水,煎煮提取三次,每次3小时,合并滤液,将滤液浓缩成相对密度1.20的浸膏,在温度为70℃~80℃,真空度为0.08~0.1Mpa的条件下将浸膏干燥,粉碎成100目细粉备用;
2)将青稞蒸煮,干燥,炒制粉碎成100目细粉备用;
3)将藏红花、手掌参、人参果、砖茶粉碎成100目细粉备用;
4)A,将上述备用物混匀,制粒,压成圆形或菱形片状,干燥即得。
Claims (2)
1.一种红景天茶,其特征在于制备其活性成分的原料是下列重量份的原料:
红景天15-25、藏红花1-3、青稞15-35、高原刺五加15-25、手掌参5-10、罗汉果10-15、人参果10-15、黄芪10-15、甘草15-25、砖茶15-30。
2.权利要求1所述太子参颗粒茶的制备方法,其特征在于包括以下步骤:
1)红景天15-25、高原刺五加15-25、罗汉果10-15、黄芪10-15、甘草15-25。加水煎煮提取三次,合并滤液,浓缩成浸膏,干燥粉碎成细粉备用;
2)将青稞蒸煮,干燥,炒制粉碎成细粉备用;
3)将藏红花、手掌参、人参果、砖茶粉碎备用;
4)A,将上述备用物混匀,制粒,压成圆形或菱形片状,干燥即得。
B,将上述备用物混匀,加入纯净水,搅拌均匀,煮沸,冷却,过滤,装罐或瓶即可。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410816991.0A CN105875913A (zh) | 2014-12-25 | 2014-12-25 | 一种红景天茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410816991.0A CN105875913A (zh) | 2014-12-25 | 2014-12-25 | 一种红景天茶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105875913A true CN105875913A (zh) | 2016-08-24 |
Family
ID=56700899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410816991.0A Pending CN105875913A (zh) | 2014-12-25 | 2014-12-25 | 一种红景天茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105875913A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106417775A (zh) * | 2016-09-29 | 2017-02-22 | 芜湖市三山区绿色食品产业协会 | 一种红景天藏红花营养茶片的制备工艺 |
CN106491983A (zh) * | 2016-12-30 | 2017-03-15 | 成都圣弘源生物科技有限公司 | 一种高原刺五加藏红花胶囊及其制备方法 |
CN107334153A (zh) * | 2017-06-22 | 2017-11-10 | 张广峰 | 一种具有清理血液杂质功能的保健食品及其加工方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1729812A (zh) * | 2005-08-18 | 2006-02-08 | 吕坤秋 | 青稞保健茶及其制备方法 |
CN102224871A (zh) * | 2011-05-23 | 2011-10-26 | 长寿时代(北京)科技有限公司 | 一种抗疲劳补肾保健茶及其制备方法 |
CN103627610A (zh) * | 2013-12-10 | 2014-03-12 | 尹治华 | 一种复方红景天酒及其制备方法 |
-
2014
- 2014-12-25 CN CN201410816991.0A patent/CN105875913A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1729812A (zh) * | 2005-08-18 | 2006-02-08 | 吕坤秋 | 青稞保健茶及其制备方法 |
CN102224871A (zh) * | 2011-05-23 | 2011-10-26 | 长寿时代(北京)科技有限公司 | 一种抗疲劳补肾保健茶及其制备方法 |
CN103627610A (zh) * | 2013-12-10 | 2014-03-12 | 尹治华 | 一种复方红景天酒及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106417775A (zh) * | 2016-09-29 | 2017-02-22 | 芜湖市三山区绿色食品产业协会 | 一种红景天藏红花营养茶片的制备工艺 |
CN106491983A (zh) * | 2016-12-30 | 2017-03-15 | 成都圣弘源生物科技有限公司 | 一种高原刺五加藏红花胶囊及其制备方法 |
CN107334153A (zh) * | 2017-06-22 | 2017-11-10 | 张广峰 | 一种具有清理血液杂质功能的保健食品及其加工方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
CN104922550A (zh) | 一种中药组合物及其应用 | |
CN101053621B (zh) | 一种治疗肥胖症的中药组合物及其制备方法 | |
CN104840550A (zh) | 一种润人参制剂及制备方法 | |
CN101537120A (zh) | 一种养颜益寿保健品 | |
CN103340405B (zh) | 一种缓解体力疲劳的保健食品及其制备方法 | |
CN110584132A (zh) | 一种肾脏病特殊医学用途营养配方食品及其制备方法 | |
CN101653494B (zh) | 一种防治猪高热病的中草药添加剂 | |
CN104825874A (zh) | 有助于尿酸代谢的傣族食品及其制备方法 | |
CN105875913A (zh) | 一种红景天茶及其制备方法 | |
CN101721667A (zh) | 一种治疗消化不良的中药 | |
CN1943692A (zh) | 生命源再生素 | |
CN104431772A (zh) | 一种润肠排毒面食制品及其制备方法 | |
CN102266511B (zh) | 一种小儿消暑健胃咀嚼片及其制备方法 | |
CN106038820A (zh) | 一种改善功能性便秘的食药同源中药组合物及其制备方法 | |
CN102366617A (zh) | 一种治疗特发性水肿的中成药 | |
CN1142785C (zh) | 抗疲劳胶囊 | |
CN102091228B (zh) | 一种治疗失眠的药物及其制备方法 | |
CN104017701B (zh) | 一种五脏衡通养生保健酒 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN105962029A (zh) | 富硒锗防癌益寿保健米粉 | |
CN106729111A (zh) | 一种治疗腹泻的颗粒及其制备方法 | |
CN102886011A (zh) | 一种治疗消化不良的中药 | |
CN101810751B (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161020 Address after: Wenjiang District 611130 of Sichuan city of Chengdu province Chengdu Strait science and Technology Industry Development Park Tsingtao Road No. 319 9-1-501, No. 9-2-501 Applicant after: CHENGDU SHENGHONGYUAN BIOLOGICAL TECHNOLOGY CO., LTD. Address before: 610000, No. 3, unit 4, building 6, 4 Siwei village, Wuhou District, Sichuan, Chengdu Applicant before: Yin Zhihua |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160824 |